• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

FAA protocol permits conductive keratoplasty for pilots


The Federal Aviation Administration (FAA) has established a protocol for airplane pilots seeking conductive keratoplasty (NearVision CK, Refractec Inc.). Before considering CK, pilots should check with their employer (if an airline) and/or flight medical examiner to determine if the treatment is an appropriate option and whether post-treatment vision meets individual requirements for flying.

Six criteria are necessary for an FAA initial certification:

  • The pilot is not qualified to fly for 6 months post-procedure.

  • The pilot must provide all medical records related to the procedure.

  • A current status report by the surgical eye specialist with special note regarding complications of the procedure or the acquired monocularity, or vision complaints by the pilot.

  • A current FAA Form 8500-7, Report of Eye Evaluation.

  • A medical flight test may be necessary (consult with the FAA).

  • Annual follow-ups by the surgical eye specialist.

For details on certification requirements and the complete protocol for CK, visit the FAA Web site, www.faa.gov.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.